Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
9.6
5.4
Journals
Marine Drugs
Special Issues
Progress on Marine Natural Products as Lead Compounds
share announcement

Progress on Marine Natural Products as Lead Compounds

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 July 2018) | Viewed by 47832

Special Issue Editors

Prof. Dr. Ana Lourenço

E-Mail Website
Guest Editor
LAQV, REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal
Interests: phytochemistry; marine metabolites; bioactive metabolites; organic chemistry
Dr. Patrícia Máximo

E-Mail Website
Guest Editor
LAQV, REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal
Interests: phytochemistry; marine metabolites; structure identification; organic chemistry

Special Issue Information

Dear Colleagues,

The development of therapeutic lead molecules encompasses many steps in different scientific areas. All converge to make headway to more efficient and available compounds. This Special Issue intends to cover progresses in molecular structures of different scaffolds that include the discovery of new compounds, the production by marine microorganisms cultures of compounds traditionally known from other sources, the knowledge of chemical diversity and bioactivity, together with synthetic approaches to produce active compounds from inactive ones, the study of the beneficial effects of compounds present in crude-drugs focused in preclinical and clinical studies, and the exploration of marine natural products by computational methodologies.

Prof. Dr. Ana Lourenço
Dr. Patrícia Máximo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural products
  • natural products analogs
  • biological activity
  • microbial production
  • marine Crude-drugs
  • preclinical and clinical studies
  • computer aided drug-discovery

Published Papers (7 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

11 pages, 1830 KiB  
Article
Chloro-Furanocembranolides from Leptogorgia sp. Improve Pancreatic Beta-Cell Proliferation
by Amalia B. Gallardo, Ana R. Díaz-Marrero, José M. De la Rosa, Luis D’Croz, Germán Perdomo, Irene Cózar-Castellano, José Darias and Mercedes Cueto
Mar. Drugs 2018, 16(2), 49; https://doi.org/10.3390/md16020049 - 02 Feb 2018
Cited by 7 | Viewed by 3480
Abstract
Two new chloro-furanocembranolides (1, 2) and two new 1,4-diketo cembranolides (3, 4) were isolated from the crude extract of Leptogorgia sp. together with a new seco-furanocembranolide (5) and the known Z-deoxypukalide (6 [...] Read more.
Two new chloro-furanocembranolides (1, 2) and two new 1,4-diketo cembranolides (3, 4) were isolated from the crude extract of Leptogorgia sp. together with a new seco-furanocembranolide (5) and the known Z-deoxypukalide (6), rubifolide (7), scabrolide D (8) and epoxylophodione (9). Their structures were determined based on spectroscopic evidence. Four compounds: 1, 2, 7 and 8 were found to activate the proliferation of pancreatic insulin-producing (beta) cells. Full article
(This article belongs to the Special Issue Progress on Marine Natural Products as Lead Compounds)
►▼ Show Figures

Figure 1

2314 KiB  
Article
Antimicrobial and Anti-Proliferative Effects of Skin Mucus Derived from Dasyatis pastinaca (Linnaeus, 1758)
by Virginia Fuochi, Giovanni Li Volti, Giuseppina Camiolo, Francesco Tiralongo, Cesarina Giallongo, Alfio Distefano, Giulio Petronio Petronio, Ignazio Barbagallo, Maria Viola, Pio Maria Furneri, Michelino Di Rosa, Roberto Avola and Daniele Tibullo
Mar. Drugs 2017, 15(11), 342; https://doi.org/10.3390/md15110342 - 01 Nov 2017
Cited by 51 | Viewed by 6689
Abstract
Resistance to chemotherapy occurs in various diseases (i.e., cancer and infection), and for this reason, both are very difficult to treat. Therefore, novel antimicrobial and chemotherapic drugs are needed for effective antibiotic therapy. The aim of the present study was to assess the [...] Read more.
Resistance to chemotherapy occurs in various diseases (i.e., cancer and infection), and for this reason, both are very difficult to treat. Therefore, novel antimicrobial and chemotherapic drugs are needed for effective antibiotic therapy. The aim of the present study was to assess the antimicrobial and anti-proliferative effects of skin mucus derived from Dasyatis pastinaca (Linnaeus, 1758). Our results showed that skin mucus exhibited a significant and specific antibacterial activity against Gram-negative bacteria but not against Gram-positive bacteria. Furthermore, we also observed a significant antifungal activity against some strains of Candida spp. Concerning anti-proliferative activity, we showed that fish mucus was specifically toxic for acute leukemia cells (HL60) with an inhibition of proliferation in a dose dependent manner (about 52% at 1000 μg/mL of fish skin mucous, FSM). Moreover, we did not observe effects in healthy cells, in neuroblastoma cells (SH-SY5Y), and multiple myeloma cell lines (MM1, U266). Finally, it exhibited strong expression and activity of chitinase which may be responsible, at least in part, for the aforementioned results. Full article
(This article belongs to the Special Issue Progress on Marine Natural Products as Lead Compounds)
►▼ Show Figures

Graphical abstract

1869 KiB  
Article
Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases
by Nadège Loaëc, Eletta Attanasio, Benoît Villiers, Emilie Durieu, Tania Tahtouh, Morgane Cam, Rohan A. Davis, Aline Alencar, Mélanie Roué, Marie-Lise Bourguet-Kondracki, Peter Proksch, Emmanuelle Limanton, Solène Guiheneuf, François Carreaux, Jean-Pierre Bazureau, Michelle Klautau and Laurent Meijer
Mar. Drugs 2017, 15(10), 316; https://doi.org/10.3390/md15100316 - 17 Oct 2017
Cited by 38 | Viewed by 5396
Abstract
A large diversity of 2-aminoimidazolone alkaloids is produced by various marine invertebrates, especially by the marine Calcareous sponges Leucetta and Clathrina. The phylogeny of these sponges and the wide scope of 2-aminoimidazolone alkaloids they produce are reviewed in this article. The origin [...] Read more.
A large diversity of 2-aminoimidazolone alkaloids is produced by various marine invertebrates, especially by the marine Calcareous sponges Leucetta and Clathrina. The phylogeny of these sponges and the wide scope of 2-aminoimidazolone alkaloids they produce are reviewed in this article. The origin (invertebrate cells, associated microorganisms, or filtered plankton), physiological functions, and natural molecular targets of these alkaloids are largely unknown. Following the identification of leucettamine B as an inhibitor of selected protein kinases, we synthesized a family of analogues, collectively named leucettines, as potent inhibitors of DYRKs (dual-specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) and potential pharmacological leads for the treatment of several diseases, including Alzheimer’s disease and Down syndrome. We assembled a small library of marine sponge- and ascidian-derived 2-aminoimidazolone alkaloids, along with several synthetic analogues, and tested them on a panel of mammalian and protozoan kinases. Polyandrocarpamines A and B were found to be potent and selective inhibitors of DYRKs and CLKs. They inhibited cyclin D1 phosphorylation on a DYRK1A phosphosite in cultured cells. 2-Aminoimidazolones thus represent a promising chemical scaffold for the design of potential therapeutic drug candidates acting as specific inhibitors of disease-relevant kinases, and possibly other disease-relevant targets. Full article
(This article belongs to the Special Issue Progress on Marine Natural Products as Lead Compounds)
►▼ Show Figures

Graphical abstract

Review

Jump to: Research

52 pages, 15525 KiB  
Review
Bioactive Prenyl- and Terpenyl-Quinones/Hydroquinones of Marine Origin †
by Pablo A. García, Ángela P. Hernández, Arturo San Feliciano and Mª Ángeles Castro
Mar. Drugs 2018, 16(9), 292; https://doi.org/10.3390/md16090292 - 21 Aug 2018
Cited by 31 | Viewed by 6478
Abstract
The sea is a rich source of biological active compounds, among which terpenyl-quinones/hydroquinones constitute a family of secondary metabolites with diverse pharmacological properties. The chemical diversity and bioactivity of those isolated from marine organisms in the last 10 years are summarized in this [...] Read more.
The sea is a rich source of biological active compounds, among which terpenyl-quinones/hydroquinones constitute a family of secondary metabolites with diverse pharmacological properties. The chemical diversity and bioactivity of those isolated from marine organisms in the last 10 years are summarized in this review. Aspects related to synthetic approaches towards the preparation of improved bioactive analogues from inactive terpenoids are also outlined. Full article
(This article belongs to the Special Issue Progress on Marine Natural Products as Lead Compounds)
►▼ Show Figures

Figure 1

28 pages, 3083 KiB  
Review
Secondary Metabolites and Biological Activity of Invasive Macroalgae of Southern Europe
by Patrícia Máximo, Luísa M. Ferreira, Paula Branco, Pedro Lima and Ana Lourenço
Mar. Drugs 2018, 16(8), 265; https://doi.org/10.3390/md16080265 - 02 Aug 2018
Cited by 46 | Viewed by 5688
Abstract
In this review a brief description of the invasive phenomena associated with algae and its consequences on the ecosystem are presented. Three examples of invasive algae of Southern Europe, belonging to Rodophyta, Chlorophyta, and Phaeophyta, were selected, and a brief [...] Read more.
In this review a brief description of the invasive phenomena associated with algae and its consequences on the ecosystem are presented. Three examples of invasive algae of Southern Europe, belonging to Rodophyta, Chlorophyta, and Phaeophyta, were selected, and a brief description of each genus is presented. A full description of their secondary metabolites and biological activity is given and a summary of the biological activity of extracts is also included. In Asparagopsis we encounter mainly halogenated compounds. From Caulerpa, several terpenoids and alkaloids were isolated, while in Sargassum, meroterpenoids prevail. Full article
(This article belongs to the Special Issue Progress on Marine Natural Products as Lead Compounds)
►▼ Show Figures

Figure 1

21 pages, 3168 KiB  
Review
Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders
by Manuel Gómez-Guzmán, Alba Rodríguez-Nogales, Francesca Algieri and Julio Gálvez
Mar. Drugs 2018, 16(8), 250; https://doi.org/10.3390/md16080250 - 28 Jul 2018
Cited by 116 | Viewed by 8606
Abstract
The beneficial effects of various polyphenols with plant origins on different cardiovascular-associated disorders, such as hypertension, diabetes mellitus type 2 and metabolic syndrome are well known. Recently, marine crude-drugs are emerging as potential treatments in many noncommunicable conditions, including those involving the cardiovascular [...] Read more.
The beneficial effects of various polyphenols with plant origins on different cardiovascular-associated disorders, such as hypertension, diabetes mellitus type 2 and metabolic syndrome are well known. Recently, marine crude-drugs are emerging as potential treatments in many noncommunicable conditions, including those involving the cardiovascular system. Among the active compounds responsible for these activities, seaweed polyphenols seem to play a key role. The aim of the present review is to summarise the current knowledge about the beneficial effects reported for edible seaweed polyphenols in the amelioration of these prevalent conditions, focusing on both preclinical and clinical studies. This review will help to establish the basis for future studies in this promising field. Full article
(This article belongs to the Special Issue Progress on Marine Natural Products as Lead Compounds)
►▼ Show Figures

Figure 1

30 pages, 5203 KiB  
Review
Computational Methodologies in the Exploration of Marine Natural Product Leads
by Florbela Pereira and Joao Aires-de-Sousa
Mar. Drugs 2018, 16(7), 236; https://doi.org/10.3390/md16070236 - 13 Jul 2018
Cited by 67 | Viewed by 10755
Abstract
Computational methodologies are assisting the exploration of marine natural products (MNPs) to make the discovery of new leads more efficient, to repurpose known MNPs, to target new metabolites on the basis of genome analysis, to reveal mechanisms of action, and to optimize leads. [...] Read more.
Computational methodologies are assisting the exploration of marine natural products (MNPs) to make the discovery of new leads more efficient, to repurpose known MNPs, to target new metabolites on the basis of genome analysis, to reveal mechanisms of action, and to optimize leads. In silico efforts in drug discovery of NPs have mainly focused on two tasks: dereplication and prediction of bioactivities. The exploration of new chemical spaces and the application of predicted spectral data must be included in new approaches to select species, extracts, and growth conditions with maximum probabilities of medicinal chemistry novelty. In this review, the most relevant current computational dereplication methodologies are highlighted. Structure-based (SB) and ligand-based (LB) chemoinformatics approaches have become essential tools for the virtual screening of NPs either in small datasets of isolated compounds or in large-scale databases. The most common LB techniques include Quantitative Structure–Activity Relationships (QSAR), estimation of drug likeness, prediction of adsorption, distribution, metabolism, excretion, and toxicity (ADMET) properties, similarity searching, and pharmacophore identification. Analogously, molecular dynamics, docking and binding cavity analysis have been used in SB approaches. Their significance and achievements are the main focus of this review. Full article
(This article belongs to the Special Issue Progress on Marine Natural Products as Lead Compounds)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-7
Back to TopTop